Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alpha Lipoic Acid in OSA
NCT05009901Phase 3Unknown
- Sponsor
- University of British Columbia
- Start
- Jun 2022
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of alpha-lipoic acid in obstructive sleep apnea (OSA), sponsored by University of British Columbia. Status: unknown.
02
Drugs
alpha-lipoic acid
03
Conditions
obstructive sleep apnea (OSA)
Beyond the preview
Go deeper on NCT05009901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05009901.